Zdrowie i gospodarka · 2.11.2018
Product Development in Hemophilia; Public Workshop
The Food and Drug Administration (FDA, the Agency, or we) is announcing the following public workshop entitled "Product Development in Hemophilia." The purpose of the public workshop is to discuss issues related to development and regulation of novel hemophilia products.